| Protagonist Therapeutics, Inc. | 5.06M | US$713M | 7.2% |
| argenx SE | 712K | US$682M | 6.9% |
| CG Oncology, Inc. | 8.51M | US$604M | 6.1% |
| iRhythm Holdings, Inc. | 3.12M | US$354M | 3.6% |
| Insmed Incorporated | 3.1M | US$353M | 3.6% |
| Tango Therapeutics, Inc. | 14M | US$351M | 3.5% |
| Erasca, Inc. | 22.4M | US$329M | 3.3% |
| Spyre Therapeutics, Inc. | 3.69M | US$329M | 3.3% |
| RadNet, Inc. | 4.63M | US$319M | 3.2% |
| Tarsus Pharmaceuticals, Inc. | 3.48M | US$274M | 2.8% |
| Zai Lab Ltd. | 10.4M | US$273M | 2.7% |
| Repligen Corporation | 1.39M | US$266M | 2.7% |
| Guardant Health, Inc. | 1.48M | US$264M | 2.7% |
| Celcuity Inc. | 3.3M | US$263M | 2.6% |
| Oruka Therapeutics, Inc. | 3.14M | US$261M | 2.6% |
| Natera, Inc. | 600K | US$248M | 2.5% |
| Cytokinetics, Incorporated | 2.86M | US$189M | 1.9% |
| Establishment Labs Holdings Inc. | 2.67M | US$171M | 1.7% |
| Xencor, Inc. | 6.83M | US$170M | 1.7% |
| Madrigal Pharmaceuticals, Inc. | 313K | US$158M | 1.6% |
| Immunocore Holdings plc | 4.87M | US$148M | 1.5% |
| Stoke Therapeutics, Inc. | 5.62M | US$146M | 1.5% |
| ACADIA Pharmaceuticals Inc. | 7.14M | US$144M | 1.5% |
| Kodiak Sciences Inc | 1.49M | US$141M | 1.4% |
| COMPASS Pathways Plc | 10.9M | US$136M | 1.4% |
| Neurocrine Biosciences, Inc. | 943K | US$134M | 1.3% |
| Ultragenyx Pharmaceutical Inc. | 8.53M | US$128M | 1.3% |
| Kailera Therapeutics, Inc. | 10.8M | US$123M | 1.2% |
| Belite Bio, Inc. | 715K | US$121M | 1.2% |
| Replimune Group, Inc. | 8.49M | US$112M | 1.1% |
| Immunovant, Inc. | 3.18M | US$107M | 1.1% |
| PTC Therapeutics, Inc. | 1.62M | US$105M | 1.1% |
| Viridian Therapeutics, Inc. | 4.91M | US$101M | 1.0% |
| Castle Biosciences, Inc. | 2.78M | US$98.7M | 0.99% |
| Cogent Biosciences, Inc. | 2.31M | US$73.9M | 0.75% |
| Structure Therapeutics, Inc. | 2.28M | US$71.4M | 0.72% |
| Axogen, Inc. | 1.66M | US$69.6M | 0.70% |
| Taysha Gene Therapies, Inc. | 13.6M | US$66M | 0.67% |
| Orchestra BioMed Holdings, Inc. | 9.56M | US$59.4M | 0.60% |
| Verastem, Inc. | 6.72M | US$54.1M | 0.55% |
| Danaher Corporation | 230K | US$51M | 0.51% |
| Hinge Health, Inc. | 500K | US$48.6M | 0.49% |
| Rocket Pharmaceuticals, Inc. | 17.7M | US$46.5M | 0.47% |
| Solid Biosciences Inc. | 5.91M | US$42.7M | 0.43% |
| Neurogene Inc. | 1.51M | US$42.1M | 0.42% |
| Cullinan Therapeutics, Inc. | 2.36M | US$36.3M | 0.37% |
| Aquestive Therapeutics, Inc. | 7.43M | US$34.4M | 0.35% |
| Candel Therapeutics, Inc. | 3.21M | US$33.5M | 0.34% |
| Aktis Oncology, Inc. | 1.59M | US$31M | 0.31% |
| Savara, Inc. | 5.95M | US$30.7M | 0.31% |
| Kymera Therapeutics, Inc. | 240K | US$26.8M | 0.27% |
| Dianthus Therapeutics, Inc. | 248K | US$21.8M | 0.22% |
| Beta Bionics, Inc. | 999K | US$19M | 0.19% |
| Larimar Therapeutics, Inc. | 5.82M | US$18.6M | 0.19% |
| Pyxis Oncology, Inc. | 6.51M | US$15.2M | 0.15% |
| Century Therapeutics, Inc. | 8.7M | US$14.9M | 0.15% |
| Beam Therapeutics Inc. | 570K | US$13.9M | 0.14% |
| Surrozen, Inc. | 394K | US$12.7M | 0.13% |
| Heartflow, Inc. | 250K | US$12.4M | 0.13% |
| Freenome, Inc. | 743K | US$11.7M | 0.12% |
| Latigo Biotherapeutics, Inc. | 700K | US$11.7M | 0.12% |
| Silence Therapeutics PLC | 700K | US$7.65M | 0.08% |
| Ocugen, Inc. | 6.67M | US$6.87M | 0.07% |
| Milestone Pharmaceuticals Inc. | 7.83M | US$6.78M | 0.07% |
| ADARx Pharmaceuticals, Inc. | 300K | US$5.98M | 0.06% |
| Crescent Biopharma, Inc. | 373K | US$5.44M | 0.05% |
| Allogene Therapeutics, Inc. | 3.25M | US$5.2M | 0.05% |
| Lumexa Imaging Holdings, Inc. | 500K | US$5.13M | 0.05% |
| Dyne Therapeutics, Inc. | 300K | US$4.83M | 0.05% |
| Regenxbio Inc. | 556K | US$4.18M | 0.04% |
| Kalaris Therapeutics, Inc. | 1.3M | US$3.76M | 0.04% |
| Abivax SA | 26,400 | US$2.61M | 0.03% |
| Medline Inc. | 70,000 | US$2.43M | 0.02% |
| Capricor Therapeutics, Inc. | 250K | US$2.37M | 0.02% |
| Disc Medicine, Inc. | 30,000 | US$1.96M | 0.02% |
| Evommune, Inc. | 208K | US$1.72M | 0.02% |
| Obsidian Therapeutics, Inc. | 67,706 | US$930K | <0.01% |
| Lexeo Therapeutics, Inc. | 239K | US$808K | <0.01% |
| Tenax Therapeutics, Inc. | 0 | US$0 | 0.00% |
| 4D Molecular Therapeutics, Inc. | 0 | US$0 | 0.00% |
| AtaiBeckley Inc. | 0 | US$0 | 0.00% |
| Avalo Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Definium Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Exagen Inc. | 0 | US$0 | 0.00% |
| IDEAYA Biosciences, Inc. | 0 | US$0 | 0.00% |
| ImageneBio, Inc. | 0 | US$0 | 0.00% |
| Maze Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Perceptive Capital Solutions Corp | 0 | US$0 | 0.00% |